Triamcinolone ointment

DRUG2 trials

Sponsors

Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Atopic DermatitisEczema

Phase 1

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

RecruitingNCT06504160

National Institute of Allergy and Infectious Diseases (NIAID)Atopic Dermatitis

Start: 2025-05-22End: 2027-02-05Target: 86Updated: 2026-07-02

Phase 4

Steroid-reducing Effects of Crisaborole

CompletedNCT03832010

Johns Hopkins UniversityAtopic Dermatitis, Eczema

Start: 2019-12-17End: 2024-02-16Updated: 2024-07-19